Helping Patients Regain Sight

LambdaVision is developing the first protein-based artificial retina to restore meaningful vision for patients who are blind or have lost significant sight due to advanced retinal degenerative diseases, including retinitis pigmentosa (RP) and age-related macular degeneration (AMD).

Both RP and AMD lead to the breakdown and loss of cells in the retina. By using proteins similar to the visual pigment rhodopsin that is naturally found in our eyes, LambdaVision’s protein-based artificial retina mimics the light-absorbing properties of human photoreceptors replacing the function of these damaged cells in the retinas of blind patients.

In The Media

Astronauts to Help Build Artificial Retinas on Space Station

SpaceX Shuttle Carries Cutting-Edge Experiment to Space Station That Could Help Vision

LambdaVision to Launch Next Investigation on NASA’s Upcoming SpaceX-24 Flight

An Artificial Retina Engineered from Ancient Protein Heads to Space | National Eye Institute

LambdaVision to Study Light-Activated Proteins on NASA’s Upcoming Flight to International Space Station

LambdaVision Secures Further NASA Funding to Utilize Company’s Advanced Production Processes for Additional Applications

Skip to content